Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-01

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer
* Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer

NCT00625625

Colorectal Cancer

UNKNOWN PHASE2

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance

NCT07310446

Colorectal Cancer

RECRUITING

Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC

NCT04912882

Colorectal Cancer Circulating Tumor Cell

NOT_YET_RECRUITING

Tumoral Circulating Cells and Colorectal Cancer Progression

NCT03256084

Colorectal Cancer

UNKNOWN NA

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

NCT03789162

Colorectal Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective project in collecting and assessing clinical outcomes data related to molecular profiling of tumors based on cancer primary or metastatic tissue or tissue from peripheral blood samples. As a future part of the project will be collected patient reported outcomes (PROs) for assessing clinical outcomes in relation to clinical pathways, patient reported results, as well as tumor profiling by molecular methods.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

open and laparoscopic surgery

Patients with primary and or metastatic colorectal cancer (CRC) eligible for curative surgery will be included. Subcohorts may be based on either colon cancer, rectal cancer, metastatic cancer, surgery (laparoscopy or open), node negative and node positive disease, and molecular profiling.

open and laparoscopic surgery

Intervention Type PROCEDURE

Curative surgery for either primary (colorectal cancer, crc) or metastatic CRC (liver surgery)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

open and laparoscopic surgery

Curative surgery for either primary (colorectal cancer, crc) or metastatic CRC (liver surgery)

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Liver surgery

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery
* Informed consent to participate
* Age ≥18